2026年全球冠狀動脈支架市場報告

近年來，冠狀動脈支架市場顯著擴張，預計將從2025年的119億美元成長到2026年的129億美元，複合年成長率為8.3%。過去幾年的成長可歸因於冠狀動脈疾病盛行率的上升、經皮冠狀動脈介入治療（PCI）手術數量的增加、支架塗層技術的進步、介入性心臟病學服務的擴展以及冠狀動脈支架置入術臨床療效的改善。

預計未來幾年冠狀動脈支架市場將維持強勁成長，到2030年市場規模將達到177.6億美元，複合年成長率（CAGR）為8.3%。預測期內的成長要素包括：人口老化加劇，心血管風險增加；對微創心臟治療的需求不斷成長；新一代支架技術的應用日益普及；對長期血管癒合和患者預後的關注度不斷提高；以及新興市場心臟護理服務的覆蓋範圍不斷擴大。預測期內的主要趨勢包括：藥物釋放型和雙效治療支架的應用日益廣泛；微創冠狀動脈介入治療越來越受歡迎；人們越來越重視降低血管再阻塞和血栓症的風險；生物可吸收和生物分解支架的使用日益增多；以及對先進支架材料和設計的需求不斷成長。

心血管疾病（CVD）盛行率的不斷上升預計將推動冠狀動脈支架市場的擴張。心血管疾病包括多種心臟和血管疾病，如冠狀動脈疾病、心臟衰竭、中風和高血壓。心血管疾病發生率的上升歸因於人口老化以及肥胖、糖尿病、缺乏運動、不健康飲食和壓力等風險因素的增加。冠狀動脈支架在治療心血管疾病中至關重要，因為它們可以疏通狹窄或阻塞的冠狀動脈，改善心臟血流，並降低心肌梗塞的風險。例如，根據美國疾病管制與預防中心（CDC）的數據，2023年心血管疾病將導致919,032人死亡，約佔所有死亡人數的三分之一。心血管疾病的這種上升趨勢正在推動對冠狀動脈支架的需求。

冠狀動脈支架市場的企業正致力於研發先進產品，例如藥物釋放型支架。與傳統的裸金屬支架相比，藥物洗脫支架能夠最大限度地減少再次手術的需求。藥物釋放型支架是一種特殊的裝置，其表面塗有藥物，可以緩慢釋放藥物，從而預防動脈血管再阻塞。例如，2024年5月，總部位於美國的醫療保健公司雅培在印度推出了XIENCE SierraEverolimus洗脫冠狀動脈支架系統。這款支架採用了改進的設計、全新的輸送系統，並針對複雜病例提供獨特的尺寸選擇。與其他XIENCE支架一樣，它也採用了特殊的塗層，可降低動脈再阻塞的風險，並擁有極高的安全性，這得益於超過120項臨床試驗（涉及超過12萬名患者）的支持。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球冠狀動脈支架市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧（AI）和自主人工智慧
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料、網路安全
  • 永續性、氣候技術和循環經濟
• 主要趨勢
  • 藥物釋放型和雙重療法支架的應用日益增多
  • 人們越來越傾向於選擇微創冠狀動脈介入治療
  • 更加重視降低血管再阻塞和血栓症的風險
  • 擴大生物可吸收和生物可分解支架的應用
  • 對先進支架材料和設計的需求不斷成長

第5章 終端用戶產業市場分析

• 醫院
• 門診手術中心
• 專科心臟診所
• 心臟導管檢查室
• 介入性心臟病中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球冠狀動脈支架市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球冠狀動脈支架市場規模、對比及成長率分析
• 全球冠狀動脈支架市場表現：規模與成長，2020-2025年
• 全球冠狀動脈支架市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 依產品類型
• 雙效支架、放射性支架、血栓切除支架、塗層支架、生物可吸收支架、生物分解支架、混合支架、藥物釋放型支架、裸金屬支架
• 透過技術
• 雷射切割、3D列印支架、微加工、奈米技術支架、電解及其他技術
• 按原料
• 鈷鉻合金、不鏽鋼、鉑鉻合金、鎳鈦合金、聚合物
• 透過部署
• 自動擴張型支架，球囊擴張型支架
• 透過使用
• 醫院及門診手術中心、專科診所及其他終端用途
• 按類型細分：雙重治療支架
• Sirolimus洗脫雙效支架、紫杉醇洗脫雙效支架、Everolimus洗脫雙效支架
• 按類型細分：放射性支架
• BETA射線支架、γ射線支架和其他放射性支架
• 按類型細分：血栓切除支架
• 手動血栓切除支架、機械血栓切除支架、液壓血栓切除支架
• 按類型細分：覆膜支架
• 聚四氟乙烯塗層支架、膨體聚四氟乙烯塗層支架、聚氨酯塗層支架及其他塗層支架
• 按類型細分：生物可吸收支架
• 聚合物基生物可吸收支架、金屬基生物可吸收支架、陶瓷基生物可吸收支架
• 按類型細分：可生物分解支架
• 可生物分解聚合物支架、鎂基可生物分解支架和其他可生物分解支架
• 按類型細分：混合支架
• 混合藥物釋放型支架、混合可生物分解或金屬支架等混合支架
• 按類型細分：藥物釋放型支架
• Sirolimus洗脫支架、紫杉醇洗脫支架、Everolimus洗脫支架、佐他莫司洗脫支架及其他藥物釋放型支架
• 按類型細分：裸金屬支架
• 不鏽鋼裸金屬支架、鈷鉻合金裸金屬支架、其他裸金屬支架

第10章 區域與國家分析

• 全球冠狀動脈支架市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
• 全球冠狀動脈支架市場：依國家、市場表現及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 冠狀動脈支架市場：競爭格局與市場佔有率，2024 年
• 冠狀動脈支架市場：公司估值矩陣
• 冠狀動脈支架市場：公司簡介
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Terumo Corporation
  • BIOTRONIK SE & Co KG

第37章：其他領先和創新企業

• B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年冠狀動脈支架市場：提供新機會的國家
• 2030年冠狀動脈支架市場：充滿新機會的細分市場
• 2030年冠狀動脈支架市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Coronary stents are small, expandable tubes used to open narrowed or blocked coronary arteries, which supply blood to the heart muscle. Typically constructed from metal mesh, these devices are inserted during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent is delivered via a balloon catheter and expanded at the blockage site to restore proper blood flow.

The main types of coronary stents include dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents integrate drug-eluting and bioresorbable technologies to offer both medication release and gradual absorption of the stent structure. Various technologies used in their manufacture include laser cutting, 3D printing, microfabrication, nanotechnology, and electropolishing. Materials used in stent production can include cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. Stents can be self-expandable or balloon-expandable and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

Tariffs are impacting the coronary stents market by increasing costs for imported raw materials such as cobalt-chromium alloys, polymers, and precision manufacturing components used in advanced stent production. These cost pressures have particularly affected drug-eluting, bioresorbable, and hybrid stent segments, with asia-pacific and europe being more exposed due to global manufacturing dependencies. Increased tariffs have raised procurement costs for hospitals and ambulatory surgical centers. However, tariffs have also encouraged localized manufacturing, material innovation, and regional supply chain diversification, supporting long-term market resilience.

The coronary stents market research report is one of a series of new reports from The Business Research Company that provides coronary stents market statistics, including coronary stents industry global market size, regional shares, competitors with a coronary stents market share, detailed coronary stents market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. This coronary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary stents market size has grown strongly in recent years. It will grow from $11.9 billion in 2025 to $12.9 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, increasing number of percutaneous coronary intervention procedures, advancements in stent coating technologies, expansion of interventional cardiology services, improved clinical outcomes of coronary stenting.

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $17.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to aging population with higher cardiovascular risk, increasing demand for minimally invasive cardiac treatments, growing adoption of next-generation stent technologies, rising focus on long-term vessel healing and patient outcomes, expanding access to cardiac care in emerging markets. Major trends in the forecast period include rising adoption of drug-eluting and dual therapy stents, increasing preference for minimally invasive coronary interventions, growing focus on reducing restenosis and thrombosis risks, expansion of bioresorbable and biodegradable stent usage, increasing demand for advanced stent materials and designs.

The growing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market. CVDs encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population, increased rates of risk factors such as obesity, diabetes, sedentary lifestyles, poor diet, and stress. Coronary stents are crucial in treating CVDs as they help open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, representing approximately one in every three deaths. This rising prevalence of CVDs is driving the demand for coronary stents.

Companies in the coronary stent market are focusing on developing advanced products such as drug-eluting stents to minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents are specialized devices coated with medication that gradually releases drugs to prevent the re-narrowing of arteries. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an enhanced design, a new delivery system, and unique size options tailored for complex cases. It maintains a specialized coating to reduce the risk of artery re-blockage, consistent with other XIENCE stents, and boasts a strong safety record supported by over 120 clinical trials involving more than 120,000 patients.

In November 2023, OrbusNeich Medical Group Holdings Limited, a China-based medical device company, acquired Eucatech AG for an undisclosed amount. Through this acquisition, OrbusNeich seeks to expand its cardiovascular product portfolio, strengthen its position in the global angioplasty and stent markets, accelerate innovation in vascular intervention solutions, and enhance its commercial presence across Europe and other key regions. Eucatech AG is a Germany-based medical device company that provides coronary stents.

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys

North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Stents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses coronary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coronary stents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Dual Therapy Stents; Radioactive Stents; Thrombectomy Stents; Covered Stents; Bioresorbable Stents; Biodegradable Stents; Hybrid Stents; Drug-Eluting Stents; Bare Metal Stents
• 2) By Technology: Laser Cutting; 3D-Printed Stents; Microfabrication; Nanotechnology-Based Stents; Electropolishing; Others Technologies
• 3) By Raw Material: Cobalt-Chromium; Stainless Steel; Platinum-Chromium; Nickel-Titanium; Polymer
• 4) By Deployment: Self-Expandable Stents; Balloon-Expandable Stents
• 5) By End Uses: Hospitals And Ambulatory Surgical Centers; Specialty Clinics; Other End Uses
• Subsegments:
• 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents; Paclitaxel-Eluting Dual Therapy Stents; Everolimus-Eluting Dual Therapy Stents
• 2) By Radioactive Stents: Beta Radiation Stents; Gamma Radiation Stents; Other Radiation Stents
• 3) By Thrombectomy Stents: Manual Thrombectomy Stents; Mechanical Thrombectomy Stents; Hydrodynamic Thrombectomy Stents
• 4) By Covered Stents: PTFE-Covered Stents; ePTFE-Covered Stents; Polyurethane-Covered Stents; Other Covered Stents
• 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents; Metal-Based Bioresorbable Stents; Ceramic-Based Bioresorbable Stents
• 6) By Biodegradable Stents: Polymeric Biodegradable Stents; Magnesium-Based Biodegradable Stents; Other Biodegradable Stents
• 7) By Hybrid Stents: Hybrid Drug-Eluting Stents; Hybrid Biodegradable Or Metal Stents; Other Hybrid Stents
• 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents; Paclitaxel-Eluting Stents; Everolimus-Eluting Stents; Zotarolimus-Eluting Stents; Other Drug-Eluting Stents
• 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents; Cobalt Chromium Bare Metal Stents; Other Bare Metal Stents
• Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; BIOTRONIK SE & Co KG; B Braun Melsungen AG; Biosensors International Group Ltd; MicroPort Scientific Corporation; Lepu Medical Technology Beijing Co Ltd; Meril Life Sciences Pvt Ltd; Stentys SA; Alvimedica; Vascular Concepts; Balton Medical; Cardionovum; HEXACATH; Elixir Medical Corporation; Translumina GmbH; Relisys Medical Devices Ltd; REVA Medical Inc; Sahajanand Medical Technologies Pvt Ltd; Endocor GmbH; Eurocor Tech; Medinol; Q3 Medical Devices; S3V Vascular Technologies; InSitu Technologies; Minvasys
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Coronary Stents Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Coronary Stents Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Coronary Stents Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Coronary Stents Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Drug-Eluting And Dual Therapy Stents
  • 4.2.2 Increasing Preference For Minimally Invasive Coronary Interventions
  • 4.2.3 Growing Focus On Reducing Restenosis And Thrombosis Risks
  • 4.2.4 Expansion Of Bioresorbable And Biodegradable Stent Usage
  • 4.2.5 Increasing Demand For Advanced Stent Materials And Designs

5. Coronary Stents Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Ambulatory Surgical Centers
• 5.3 Specialty Cardiology Clinics
• 5.4 Cardiac Catheterization Laboratories
• 5.5 Interventional Cardiology Centers

6. Coronary Stents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Coronary Stents Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Coronary Stents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Coronary Stents Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Coronary Stents Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Coronary Stents Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Coronary Stents Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Coronary Stents Market Segmentation

• 9.1. Global Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
• 9.2. Global Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Other Technologies
• 9.3. Global Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer
• 9.4. Global Coronary Stents Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Self-Expandable Stents, Balloon-Expandable Stents
• 9.5. Global Coronary Stents Market, Segmentation By End Uses, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
• 9.6. Global Coronary Stents Market, Sub-Segmentation Of Dual Therapy Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
• 9.7. Global Coronary Stents Market, Sub-Segmentation Of Radioactive Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
• 9.8. Global Coronary Stents Market, Sub-Segmentation Of Thrombectomy Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
• 9.9. Global Coronary Stents Market, Sub-Segmentation Of Covered Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
• 9.10. Global Coronary Stents Market, Sub-Segmentation Of Bioresorbable Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
• 9.11. Global Coronary Stents Market, Sub-Segmentation Of Biodegradable Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
• 9.12. Global Coronary Stents Market, Sub-Segmentation Of Hybrid Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
• 9.13. Global Coronary Stents Market, Sub-Segmentation Of Drug-Eluting Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
• 9.14. Global Coronary Stents Market, Sub-Segmentation Of Bare Metal Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

10. Coronary Stents Market Regional And Country Analysis

• 10.1. Global Coronary Stents Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Coronary Stents Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Coronary Stents Market

• 11.1. Asia-Pacific Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Coronary Stents Market

• 12.1. China Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Coronary Stents Market

• 13.1. India Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Coronary Stents Market

• 14.1. Japan Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Coronary Stents Market

• 15.1. Australia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Coronary Stents Market

• 16.1. Indonesia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Coronary Stents Market

• 17.1. South Korea Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Coronary Stents Market

• 18.1. Taiwan Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Coronary Stents Market

• 19.1. South East Asia Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Coronary Stents Market

• 20.1. Western Europe Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Coronary Stents Market

• 21.1. UK Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Coronary Stents Market

• 22.1. Germany Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Coronary Stents Market

• 23.1. France Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Coronary Stents Market

• 24.1. Italy Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Coronary Stents Market

• 25.1. Spain Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Coronary Stents Market

• 26.1. Eastern Europe Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Coronary Stents Market

• 27.1. Russia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Coronary Stents Market

• 28.1. North America Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Coronary Stents Market

• 29.1. USA Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Coronary Stents Market

• 30.1. Canada Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Coronary Stents Market

• 31.1. South America Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Coronary Stents Market

• 32.1. Brazil Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Coronary Stents Market

• 33.1. Middle East Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Coronary Stents Market

• 34.1. Africa Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Coronary Stents Market Regulatory and Investment Landscape

36. Coronary Stents Market Competitive Landscape And Company Profiles

• 36.1. Coronary Stents Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Coronary Stents Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Coronary Stents Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. BIOTRONIK SE & Co KG Overview, Products and Services, Strategy and Financial Analysis

37. Coronary Stents Market Other Major And Innovative Companies

• B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc

38. Global Coronary Stents Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Coronary Stents Market

40. Coronary Stents Market High Potential Countries, Segments and Strategies

• 40.1 Coronary Stents Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Coronary Stents Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Coronary Stents Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer